different strength [Design Issues]

posted by ioanam – Romania, 2007-03-18 01:27 (7039 d 03:04 ago) – Posting: # 584
Views: 5,087

Dear Sir,
I have to perform a bioequivalence study with two strengths (120 mg and 160 mg) for a modified release formulation, which are not dose proportional. The Orange book specifies only 160 mg formulation as RLD. There is also an innovator for 120 mg, but it is not listed as RLD. In that case what shall be the reference drug for 120mg strength?
Thank you.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
123 visitors (0 registered, 123 guests [including 15 identified bots]).
Forum time: 05:31 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5